| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Psychosomatic Medicine, Vol 49, Issue 4 397-409, Copyright © 1987 by American Psychosomatic Society
ORIGINAL ARTICLES |
BB Sherwin and MM Gelfand
Five aspects of sexual behavior were monitored daily in three groups of women who had undergone total abdominal hysterectomy and bilateral salpingo-oophorectomy approximately 4 years ago for benign disease. One group had been receiving an estrogen-androgen preparation intramuscularly once a month since their surgery (E-A). The second group had been receiving estrogen alone (E) and the third group of women had remained untreated. Plasma estradiol and testosterone were measured at an established baseline and again on days 2, 4, 8, 15, 21, and 28 postinjection. Women who received both sex steroids reported higher rates of sexual desire (p less than 0.01), sexual arousal (p less than 0.01), and numbers of fantasies (p less than 0.01) than those who were either given E or who were untreated. Moreover, changes in these behaviors covaried with plasma testosterone but not with plasma estradiol levels during the treatment month as the drug was being metabolized. Rates of coitus and orgasm were also higher in the E-A group during the first two postinjection weeks (p less than 0.01) coincident with their higher testosterone levels. These findings imply that androgen may be critical for the maintenance of optimal levels of sexual functioning in postmenopausal women.
This article has been cited by other articles:
 |
|
 |
|
  S. Basaria and A. S. Dobs Controversies Regarding Transdermal Androgen Therapy in Postmenopausal Women J. Clin. Endocrinol. Metab., December 1, 2006; 91(12): 4743 - 4752. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Wierman, R. Basson, S. R. Davis, S. Khosla, K. K. Miller, W. Rosner, and N. Santoro Androgen Therapy in Women: An Endocrine Society Clinical Practice Guideline J. Clin. Endocrinol. Metab., October 1, 2006; 91(10): 3697 - 3710. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. B. Singh, M. L. Lee, I. Sinha-Hikim, M. Kushnir, W. Meikle, A. Rockwood, S. Afework, and S. Bhasin Pharmacokinetics of a Testosterone Gel in Healthy Postmenopausal Women J. Clin. Endocrinol. Metab., January 1, 2006; 91(1): 136 - 144. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F Labrie, V Luu-The, A Belanger, S-X Lin, J Simard, G Pelletier, and C Labrie Is dehydroepiandrosterone a hormone? J. Endocrinol., November 1, 2005; 187(2): 169 - 196. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J Bancroft The endocrinology of sexual arousal J. Endocrinol., September 1, 2005; 186(3): 411 - 427. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Simon, G. Braunstein, L. Nachtigall, W. Utian, M. Katz, S. Miller, A. Waldbaum, C. Bouchard, C. Derzko, A. Buch, et al. Testosterone Patch Increases Sexual Activity and Desire in Surgically Menopausal Women with Hypoactive Sexual Desire Disorder J. Clin. Endocrinol. Metab., September 1, 2005; 90(9): 5226 - 5233. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. D. Braunstein, D. A. Sundwall, M. Katz, J. L. Shifren, J. E. Buster, J. A. Simon, G. Bachman, O. A. Aguirre, J. D. Lucas, C. Rodenberg, et al. Safety and Efficacy of a Testosterone Patch for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women: A Randomized, Placebo-Controlled Trial Arch Intern Med, July 25, 2005; 165(14): 1582 - 1589. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. R. Davis, S. L. Davison, S. Donath, and R. J. Bell Circulating Androgen Levels and Self-reported Sexual Function in Women JAMA, July 6, 2005; 294(1): 91 - 96. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. Buster, S. A. Kingsberg, O. Aguirre, C. Brown, J. G. Breaux, A. Buch, C. A. Rodenberg, K. Wekselman, and P. Casson Testosterone Patch for Low Sexual Desire in Surgically Menopausal Women: A Randomized Trial Obstet. Gynecol., May 1, 2005; 105(5): 944 - 952. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L.M. Rivera-Woll, M. Papalia, S.R. Davis, and H.G. Burger Androgen insufficiency in women: diagnostic and therapeutic implications Hum. Reprod. Update, September 1, 2004; 10(5): 421 - 432. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Labrie, V. Luu-The, C. Labrie, A. Belanger, J. Simard, S.-X. Lin, and G. Pelletier Endocrine and Intracrine Sources of Androgens in Women: Inhibition of Breast Cancer and Other Roles of Androgens and Their Precursor Dehydroepiandrosterone Endocr. Rev., April 1, 2003; 24(2): 152 - 182. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. R Ragucci and N. S Culhane Treatment of Female Sexual Dysfunction Ann. Pharmacother., April 1, 2003; 37(4): 546 - 555. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Modugno, R. B. Ness, S. Ewing, and J. A. Cauley Effect of Raloxifene on Sexual Function in Older Postmenopausal Women With Osteoporosis Obstet. Gynecol., February 1, 2003; 101(2): 353 - 361. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Z. Leder, K. M. LeBlanc, C. Longcope, H. Lee, D. H. Catlin, and J. S. Finkelstein Effects of Oral Androstenedione Administration on Serum Testosterone and Estradiol Levels in Postmenopausal Women J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5449 - 5454. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. Dobs, T. Nguyen, C. Pace, and C. P. Roberts Differential Effects of Oral Estrogen versus Oral Estrogen-Androgen Replacement Therapy on Body Composition in Postmenopausal Women J. Clin. Endocrinol. Metab., April 1, 2002; 87(4): 1509 - 1516. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Berglund, M. Nystedt, C. Bolund, P.-O. Sjoden, and L.-E. Rutquist Effect of Endocrine Treatment on Sexuality in Premenopausal Breast Cancer Patients: A Prospective Randomized Study J. Clin. Oncol., June 1, 2001; 19(11): 2788 - 2796. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Shifren, G. D. Braunstein, J. A. Simon, P. R. Casson, J. E. Buster, G. P. Redmond, R. E. Burki, E. S. Ginsburg, R. C. Rosen, S. R. Leiblum, et al. Transdermal Testosterone Treatment in Women with Impaired Sexual Function after Oophorectomy N. Engl. J. Med., September 7, 2000; 343(10): 682 - 688. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Javanbakht, A. B. Singh, N. A. Mazer, G. Beall, I. Sinha-Hikim, R. Shen, and S. Bhasin Pharmacokinetics of a Novel Testosterone Matrix Transdermal System in Healthy, Premenopausal Women and Women Infected with the Human Immunodeficiency Virus J. Clin. Endocrinol. Metab., July 1, 2000; 85(7): 2395 - 2401. [Abstract] [Full Text]
|
|
|
|
|
|
H. M. Buckler, W. R. Robertson, and F. C. W. Wu Which Androgen Replacement Therapy for Women? J. Clin. Endocrinol. Metab., November 1, 1998; 83(11): 3920 - 3924. [Abstract] [Full Text]
|
|
|
|
|
|
F. Labrie, P. Diamond, L. Cusan, J.-L. Gomez, A. Belanger, and B. Candas Effect of 12-Month Dehydroepiandrosterone Replacement Therapy on Bone, Vagina, and Endometrium in Postmenopausal Women J. Clin. Endocrinol. Metab., October 1, 1997; 82(10): 3498 - 3505. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Androgen Replacement: An Idea Whose Time Hasn't Come Journal Watch Women's Health, September 1, 1996; 1996(901): 22 - 22. [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
